Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations

William Bruno; Claudia Martinuzzi; Bruna Dalmasso; Virginia Andreotti; Lorenza Pastorino; Francesco Cabiddu; Marina Gualco; Francesco Spagnolo; Alberto Ballestrero; Paola Queirolo; Federica Grillo; Luca Mastracci; Paola Ghiorzo

doi:10.18632/oncotarget.25684

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations

PDF | How to cite

Oncotarget. 2018; 9:28798-28798. https://doi.org/10.18632/oncotarget.25684

Metrics: PDF 1463 views | ?

William Bruno¹, Claudia Martinuzzi¹, Bruna Dalmasso¹, Virginia Andreotti¹, Lorenza Pastorino¹, Francesco Cabiddu², Marina Gualco², Francesco Spagnolo³, Alberto Ballestrero¹, Paola Queirolo³, Federica Grillo^4,*, Luca Mastracci^4,* and Paola Ghiorzo^1,*

¹Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa and Ospedale Policlinico San Martino, Genoa, Italy
²Pathology Unit, Ospedale Policlinico San Martino, Genoa, Italy
³Department of Medical Oncology, Ospedale Policlinico San Martino, Genoa, Italy
⁴Department of Surgical and Diagnostic Sciences, Pathology Unit, University of Genoa and Ospedale Policlinico San Martino, Genoa, Italy
^*These authors contributed equally to this work

Published: June 19, 2018

This article has been corrected: The proper listing of author names is given below:

Original article: 2018; 9:5691-5702. DOI: https://doi.org/10.18632/oncotarget.23204.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25684

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations